Fig. 3From: Increased lesion detectability in patients with locally advanced breast cancer—A pilot study using dynamic whole-body [18F]FDG PET/CTQuantitative lesion visibility a) TBR(SUV) vs. TBR(MRFDG) for all lesions in all patients, b) CNR(SUV) vs. CNR(MRFDG) for all lesions in all patients, c) TBR(SUV) vs. TBR(MRFDG) for ALN metastases, d) CNR(SUV) vs. CNR(MRFDG) for ALN metastasesBack to article page